Immune Modulation with Thymosin Alpha 1 Treatment.

King, R et al.·Vitamins and hormones·2016·
RPEP-029892016RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Thymosin alpha 1 acts via Toll-like receptors on myeloid and plasmacytoid dendritic cells, triggering signaling pathways that increase immune-related cytokine production and improve immune cell subsets, indicating its potential to treat immune suppression in various diseases.

Key Numbers

How They Did This

This article summarizes extensive preclinical and clinical studies investigating thymosin alpha 1’s effects on immune cell subsets and immune function across different disease models and conditions.

Why This Research Matters

Understanding how thymosin alpha 1 modulates immune cells can guide development of therapies for immune suppression caused by aging, infections, or cancer, potentially improving patient outcomes.

What This Study Doesn't Tell Us

The review does not specify the strength or design details of the included studies, limiting assessment of the robustness of the evidence.

Trust & Context

Original Title:
Immune Modulation with Thymosin Alpha 1 Treatment.
Published In:
Vitamins and hormones, 102, 151-78 (2016)
Authors:
King, R, Tuthill, C(2)
Database ID:
RPEP-02989

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-02989·https://rethinkpeptides.com/research/RPEP-02989

APA

King, R; Tuthill, C. (2016). Immune Modulation with Thymosin Alpha 1 Treatment.. Vitamins and hormones, 102, 151-78. https://doi.org/10.1016/bs.vh.2016.04.003

MLA

King, R, et al. "Immune Modulation with Thymosin Alpha 1 Treatment.." Vitamins and hormones, 2016. https://doi.org/10.1016/bs.vh.2016.04.003

RethinkPeptides

RethinkPeptides Research Database. "Immune Modulation with Thymosin Alpha 1 Treatment." RPEP-02989. Retrieved from https://rethinkpeptides.com/research/king-2016-immune-modulation-with-thymosin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.